Recent Articles
Patients with pediatric cancer often experience reduced physical activity (PA) due to treatment-related fatigue, functional limitations, and lack of structured exercise programs. Digital health solutions, including wearable sensors and augmented reality (AR)-based interventions, may offer new possibilities for monitoring and improving PA in this population.
Nearly 250,000 cancer cases are diagnosed annually in Canada, with breast and prostate cancer representing 25% and 22% of new cases, respectively. Access to cancer care is often fraught with barriers and delays due to limited healthcare resources. Artificial Intelligence (AI) applications can potentially improve the accuracy, efficiency, and timeliness of cancer care, including screening, diagnostic imaging, and early treatment. However, patient acceptability of AI in cancer care remains underexplored.
Hyperthermic intraperitoneal chemotherapy (HIPEC) has been integrated into the management of gastric cancer (GC) as a combined approach for addressing peritoneal metastasis, serving both prophylactic and therapeutic roles following GC surgery. The pivotal decision regarding HIPEC administration typically arises intraoperatively, creating a complex clinical scenario where family caregivers must act as surrogate decision-makers under substantial time constraints. This decision-making process proves particularly challenging due to limited understanding of the procedure’s risk-benefit profile and long-term outcomes among nonmedical surrogates, challenges often exacerbated by the acute stress of the surgical environment.
Renal cell carcinomas (RCCs) is a common, often letal kidney cancer that originates in the renal cortex. Its incidence is rising, and major factors include smoking, obesity, and hypertension, though its ethiology is uncertain. While surgery is effective for localized RCC, treatments for metastic RCC have advanced significantly due to better diagnostic, prognostic and predictive tools. Despite this progress, challenges remain, including long-term drug resistance and the complexity of RCC as a diverse group of diseases rather than a single entity.
Individuals undergoing cancer treatment often face a high symptom burden that impairs quality of life. Exercise and mind-body therapies have been shown to reduce symptoms but are underused. We developed a digital exercise and mind-body therapy program that effectively reduces symptoms while overcoming in-person delivery barriers. Understanding patient experiences can inform treatment mechanisms and guide digital health interventions in cancer care.
Cancer survivors face significant challenges in maintaining adequate physical activity levels, which are essential for overall health and quality of life. Telehealth-based interventions offer promising opportunities to provide accessible support and promote healthier lifestyles throughout the cancer survivorship continuum. HealthScore is a telehealth coaching program designed to optimize the health of cancer survivors.
People surviving breast cancer often face long-term impairments in physical function, significantly impacting their quality of life. In recent years, a variety of technologies have been developed to monitor and assess these functions; however, there is no consolidated synthesis linking specific technologies to targeted functional domains and real-world clinical contexts, limiting comparability and translation into practice.
Immune checkpoint inhibitors (ICIs) have emerged as a pivotal treatment for advanced esophageal squamous cell carcinoma (ESCC). However, their efficacy can significantly differ among patients, highlighting the need for reliable prognostic markers to enhance treatment outcomes. Lactate dehydrogenase (LDH) plays a key regulatory role in the complex relationship between cancer metabolism and the immune system, suggesting that monitoring LDH levels may provide valuable insights into treatment efficacy and inform personalized therapeutic strategies for advanced ESCC.
